Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hedgehog Signaling Pathway

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...

Hedgehog Signaling Pathway

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adapting UK Clinical Practise in Chronic Myeloid Leukaemia in Chronic Phase to Contemporary Management Recommendations: The ADAPT 2.0 Survey.

European journal of haematology·2026

Same author

Introducing a prognostic score for successful treatment-free remission in chronic myeloid leukaemia.

British journal of haematology·2026

Same author

A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

Blood·2026

Same author

Venetoclax-based non-intensive combinations for relapsed/refractory acute myeloid leukaemia-Real-world data from a UK-wide programme.

British journal of haematology·2025

Same author

Comparative autofluorescence analysis of silicon nitride and tantalum pentoxide waveguides at 532 nm.

Optics express·2025

Same author

TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.

Nature medicine·2024

Search research articles

Related Experiment Video

Updated: May 26, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

Targeting hedgehog in hematologic malignancy.

David A Irvine¹, Mhairi Copland

¹Paul O'Gorman Leukaemia Research Centre, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom.

|January 7, 2012

Summary

This summary is machine-generated.

The Hedgehog pathway is vital for embryonic development and blood formation. While its role in adult hematopoiesis is debated, inhibiting it may target leukemia stem cells, offering a novel cancer therapy approach.

More Related Videos

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Cell Population Analyses During Skin Carcinogenesis

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

Related Experiment Videos

Last Updated: May 26, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Cell Population Analyses During Skin Carcinogenesis

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

Area of Science:

Molecular Biology
Developmental Biology
Oncology

Background:

The Hedgehog pathway regulates embryonic development, including hematopoiesis.
Its role in adult hematopoiesis is controversial, but abnormal signaling is linked to cancers.
Leukemic stem cells may depend on this pathway for survival and proliferation.

Purpose of the Study:

To review the Hedgehog pathway's role in normal and malignant hematopoiesis.
To discuss the development of Hedgehog pathway inhibitors.
To explore the therapeutic potential of these inhibitors in hemato-oncology.

Main Methods:

Literature review of the Hedgehog pathway.
Analysis of its function in hematopoiesis and hematologic malignancies.
Examination of clinical trials for Hedgehog pathway inhibitors.

Main Results:

Hedgehog signaling is crucial for embryonic hematopoiesis but may be dispensable in adults.
Aberrant Hedgehog signaling promotes hematologic malignancies and leukemic stem cell maintenance.
Clinical trials are evaluating Hedgehog pathway inhibitors for myeloid leukemias.

Conclusions:

The Hedgehog pathway presents a potential therapeutic target in hemato-oncology.
Inhibiting this pathway could selectively target leukemic stem cells resistant to chemotherapy.
Further research and clinical trials are warranted to establish its efficacy.